Last updated on August 2017

Severe Uncontrolled Asthma

Brief description of study

Severe Uncontrolled Asthma

Detailed Study Description

A multi-centered, randomized, double-blind, parelled, placebo-controlled, phase 3B study to evaluate the safety and efficacy of Benralizumab 30 mg sc in patients with severe ssthma uncontrolled on standard of care treatment.

Clinical Study Identifier: TX151880

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.